Fulminant clostridium difficile colitis: Prospective development of a risk scoring system

Journal of Trauma and Acute Care Surgery

Volumn 76, Issue 2, 2014, Pages 424-430

  Van Der Wilden, Gwendolyn M ^a,b   Chang, Yuchiao ^a   Cropano, Catrina ^a   Subramanian, Melanie ^a   Schipper, Inger B ^b   Yeh, D Dante ^a   King, David R ^a   De Moya, Marc A ^a   Fagenholz, Peter J ^a   Velmahos, George C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

clinical prediction rule; Fulminant Clostridium difficile colitis; risk scoring system

Indexed keywords

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; COHORT STUDIES; DISEASE PROGRESSION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84894202112     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000105     Document Type: Article

References (40)

1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431-455.
2. Kyne L, HamelMB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34(3):346-353.
3. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridiumdifficile colitis in hospitalized patients in the United States. Arch Surg. 2007;142(7):624-631; discussion 631.
4. Lucado J GC, Elishauser A. Clostridiumdifficile infections (CDI) in hospital stays, 2009. HCUP statistical brief no. 124. 2011.
5. Kent KC, Rubin MS, Wroblewski L, Hanff PA, Silen W. The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients. Ann Surg. 1998;227(2):296-301.
6. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum. 1995;38(4):350-354.
7. Sailhamer EA, Carson K, Chang Y, Zacharias N, Spaniolas K, Tabbara M, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg. 2009;144(5):433-439; discussion 439-440.
8. Vasaly FW, Reines D. A quality committee's evaluation of surgical intervention for Clostridium difficile infection. AORN J. 2009;90(2):192-200; quiz 201-204.
9. Ali SO, Welch JP, Dring RJ. Early surgical intervention for fulminant pseudomembranous colitis. Am Surg. 2008;74(1):20-26.
10. Byrn JC,MaunDC,GingoldDS, BarilDT,Ozao JJ,DivinoCM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008;143(2):150-154; discussion 155.
11. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002;235(3):363-372.
12. Greenstein AJ, Byrn JC, Zhang LP, Swedish KA, Jahn AE, Divino CM. Risk factors for the development of fulminant Clostridium difficile colitis. Surgery. 2008;143(5):623-629.
13. Hall JF, Berger D. Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management. Am J Surg. 2008;196(3):384-388.
14. Jaber MR, Olafsson S, Fung WL, Reeves ME. Clinical review of the management of fulminant Clostridium difficile infection. Am J Gastroenterol. 2008;103(12):3195-3203; quiz 3204.
15. Koss K, Clark MA, Sanders DS, Morton D, Keighley MR, Goh J. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis. 2006;8(2):149-154.
16. Lamontagne F, Labbe AC, Haeck O, Lesur O, Lalancette M, Patino C, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245(2):267-272.
17. Longo WE, Mazuski JE, Virgo KS, Lee P, Bahadursingh AN, Johnson FE. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum. 2004;47(10):1620-1626.
18. Markelov A, Livert D, Kohli H. Predictors of fatal outcome after colectomy for fulminant Clostridium difficile colitis: a 10-year experience. Am Surg. 2011;77(8):977-980.
19. Miller AT, Tabrizian P, Greenstein AJ, Dikman A, Byrn J, Divino C. Longterm follow-up of patients with fulminant Clostridium difficile colitis. J Gastrointest Surg. 2009;13(5):956-959.
20. Pepin J, Vo TT, Boutros M, Marcotte E, Dial S, Dube S, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum. 2009;52:400-405.
21. Perera AD, Akbari RP, Cowher MS, Read TE, McCormick JT, Medich DS, et al. Colectomy for fulminant Clostridium difficile colitis: predictors of mortality. Am Surg. 2010;76(4):418-421.
22. Seder CW, Villalba MR Jr, Robbins J, Ivascu FA, Carpenter CF, Dietrich M, et al. Early colectomy may be associated with improved survival in fulminant Clostridium difficile colitis: an 8-year experience. Am J Surg. 2009;197(3):302-307.
23. Synnott K,Mealy K, Merry C,Kyne L, Keane C,Quill R. Timing of surgery for fulminating pseudomembranous colitis. Br J Surg. 1998;85(2):229-231.
24. Neal MD, Alverdy JC, Hall DE, Simmons RL, Zuckerbraun BS. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011;254(3):423-427; discussion 427-429.
25. Gagliardi AR, Brouwers MC, Palda VA, Lemieux-Charles L, Grimshaw JM. How can we improve guideline use? A conceptual framework of implementability. Implement Sci. 2011;6:26.
26. Kastner M, Estey E, Bhattacharyya O. Better guidelines for better care: enhancing the implementability of clinical practice guidelines. Expert Rev Pharmacoecon Outcomes Res. 2011;11(3):315-324.
27. Butala P, Divino CM. Surgical aspects of fulminant Clostridium difficile colitis. Am J Surg. 2010;200(1):131-135.
28. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23(10):1631-1660.
29. Girotra M, Kumar V, Khan JM, Damisse P, Abraham RR, Aggarwal V, et al. Clinical predictors of fulminant colitis in patients with Clostridium difficile infection. Saudi J Gastroenterol. 2012;18(2):133-139.
30. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet. 2002;359(9309):881-884.
31. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005;353(23):2433-2441.
32. Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K, et al. Clostridium difficileYassociated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004;171(5):466-472.
33. Loo VG, Poirier L, Miller MA, Oughton M, LibmanMD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficileYassociated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442-2449.
34. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficileYassociated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005;173(9):1037-1042.
35. Chandra S, LattN, JariwalaU, PalabindalaV, ThapaR,Alamelumangapuram CB, et al. A cohort study for derivation and validation of a clinical prediction scale for hospital-onset Clostridium difficile infection. Can J Gastroenterol. 2012;26(12):885-888.
36. Dubberke ER, Yan Y, Reske KA, Butler AM, Doherty J, Pham V, et al. Development and validation of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol. 2011;32(4):360-366.
37. Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. J Hosp Infect. 2008; 70(2):142-147.
38. HuMY,Katchar K,Kyne L, Maroo S,Tummala S, DreisbachV, et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology. 2009;136(4):1206-1214.
39. Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol. 2002;23(11):653-659.
40. Tanner J, Khan D, Anthony D, Paton J.Waterlow score to predict patients at risk of developing Clostridium difficileYassociated disease. J Hosp Infect. 2009;71(3):239-244.